Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children
Ling Hou,1,* Zhi-hang Chen,2,* Dong Liu,3 Yuan-guo Cheng,2 Xiao-ping Luo1 1Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 2Department of Pharmacy, Beijing Institute of Microbiology and Epidemiology, Beijing, 3Department of Ph...
Main Authors: | Hou L, Chen ZH, Liu D, Cheng YG, Luo XP |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-12-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/comparative-pharmacokinetics-and-pharmacodynamics-of-a-pegylated-recom-peer-reviewed-article-DDDT |
Similar Items
-
The pharmacokinetic and pharmacodynamic properties and short-term outcome of a novel once-weekly PEGylated recombinant human growth hormone for children with growth hormone deficiency
by: Yan Liang, et al.
Published: (2022-08-01) -
Reduced Effectiveness and Comparable Safety in Biweekly vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial
by: Chengjun Sun, et al.
Published: (2021-11-01) -
Effects of recombinant human growth hormone administration on cardiovascular risk factors in obese children with relative growth hormone deficiency
by: Shuang Liang, et al.
Published: (2018-04-01) -
Long-term response to recombinant human growth hormone therapy in Indian children with growth hormone deficiency
by: Monita Gahlot, et al.
Published: (2019-01-01) -
Long‐acting growth hormone in 2022
by: Margaret Steiner, et al.
Published: (2023-03-01)